A
Arcellx
Biotech & Life Sciences · Gaithersburg, United States · Founded 2015 · IPO 2022
Intelligent and adaptive cell therapies to treat the complexity of human disease MoreLess
Arcellx is a clinical-stage biotechnology company focused on developing innovative immunotherapies to transform cell therapy. The company operates in the biopharmaceutical sector, targeting diseases that can be treated through advanced cell therapy techniques. Arcellx's primary clients include healthcare providers, research institutions, and patients in need of cutting-edge treatments for serious conditions. The business model revolves around the research, development, and commercialization of proprietary immunotherapy products. Revenue is generated through partnerships, licensing agreements, and eventual product sales upon regulatory approval. Arcellx aims to address unmet medical needs by leveraging its expertise in cell therapy to create effective and safe treatment options.
Keywords: biotechnology, immunotherapy, cell therapy, clinical-stage, biopharmaceutical, healthcare, research, development, commercialization, treatment
Talent graph
Arcellx's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Arcellx has talent and traffic
team presence
across markets
Patent intelligence
$14M patent portfolio · 9 active families
Where Arcellx concentrates vs peers
Each axis is a top-10 topic across Arcellx and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about Arcellx
An AI-synthesized read of the highest-engagement posts about Arcellx on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Arcellx on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.